Psych Vivas · General adult psychiatry — personality disorders
Schizotypal personality disorder — structured clinical viva
Fellowship viva covering STPD criteria, schizophrenia and ASD differentials, conversion monitoring, limited antipsychotic evidence, comorbidity treatment, and anti-nihilism psychosocial care.
On this page & tools
Target exams
Interpretation
Reveal interpretation
This presentation is most consistent with schizotypal personality disorder if a longitudinal pattern meets DSM ≥5 of 9 features with general PD criteria: cognitive-perceptual oddness (ideas of reference with residual doubt), interpersonal deficits, and eccentricity, without frank sustained psychosis. Working part-time and questioning referential ideas argue against current schizophrenia, but you must still take a full history for duration, functional trajectory, substances, depression, ASD developmental profile, and family history.[1][2]
Risk. Separate (a) suicide/self-neglect risk linked to depression and isolation from (b) conversion risk if conviction and function worsen, and (c) parenting capacity/safeguarding, which depends on functional impairment, insight, and specific behaviours — oddness alone is not automatic child removal. Assess capacity decision-specifically and act on statutory safeguarding duties when indicated without inventing foreign legal sections.[1][5]
Treatment answer to the GP. Psychotherapy/alliance-first psychosocial care is foundational. No antipsychotic is a disease-modifying “personality drug.” Time-limited low-dose antipsychotic trials may be considered for severe cognitive-perceptual distress with targets and review dates; evidence certainty is limited (Jakobsen; Kirchner; Gundersen GRADE). Treat depression/anxiety properly. Monitor conversion and escalate to early psychosis pathways if frank psychosis or UHR thresholds with decline emerge.[2][3][4][5]
Key points
[2] [5]References
- [1]Rosell DR, Futterman SE, McMaster A, Siever LJ Schizotypal personality disorder: a current review Curr Psychiatry Rep, 2014.PMID 24828284
- [2]Kirchner SK, Roeh A, Nolden J, Hasan A Diagnosis and treatment of schizotypal personality disorder: evidence from a systematic review NPJ Schizophr, 2018.PMID 30282970
- [3]Jakobsen KD, Skyum E, Hashemi N, Schjerning O, et al. Antipsychotic treatment of schizotypy and schizotypal personality disorder: a systematic review J Psychopharmacol, 2017.PMID 28347257
- [4]Gundersen KB, Arnfred B, Albert N, Rasmussen AR, et al. Treatment of schizotypal disorder: A systematic review and GRADE evaluation of the certainty of evidence Schizophr Res, 2026.PMID 41421074
- [5]Fusar-Poli P, Salazar de Pablo G, Correll CU, et al. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention JAMA Psychiatry, 2020.PMID 32159746